Technology

NuVasive

$57.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-0.09%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NuVasive and other stocks, options, and ETFs commission-free!

About NUVA

NuVasive, Inc. engages in the development of minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. It offers cervical and spine fusion surgery, cervical plating, and posterior fixation products. The company was founded by Alexis V. Lukianov on July 21, 1997 and is headquartered in San Diego, CA. The listed name for NUVA is NuVasive, Inc. Common Stock.

CEO
J. Christopher Barry
Employees
2,800
Headquarters
San Diego, California
Founded
1997
Market Cap
2.91B
Price-Earnings Ratio
Dividend Yield
Average Volume
816.72K
High Today
$58.58
Low Today
$55.78
Open Price
$56.39
Volume
809.79K
52 Week High
$81.00
52 Week Low
$28.55

Collections

NUVA Earnings

-$0.52
-$0.10
$0.31
$0.73
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 18, After Hours

You May Also Like

HTRB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure